Pyrimethamine
- Generic Name
- Pyrimethamine
- Brand Names
- Daraprim
- Drug Type
- Small Molecule
- Chemical Formula
- C12H13ClN4
- CAS Number
- 58-14-0
- Unique Ingredient Identifier
- Z3614QOX8W
Overview
One of the folic acid antagonists that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.
Background
One of the folic acid antagonists that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.
Indication
For the treatment of toxoplasmosis and acute malaria; For the prevention of malaria in areas non-resistant to pyrimethamine
Associated Conditions
- Toxoplasmosis
Clinical Trials
FDA Approved Products
Pyrimethamine
Manufacturer:DR.REDDYS LABORATORIES INC
Route:ORAL
Strength:25 mg in 1 1
Approved: 2023/03/20
NDC:43598-672
Daraprim
Manufacturer:TILDE Sciences LLC
Route:ORAL
Strength:25 mg in 1 1
Approved: 2023/12/07
NDC:83649-330
Pyrimethamine Leucovorin
Manufacturer:South Coast Specialty Compounding, Inc. d/b/a Park Compounding
Route:ORAL
Strength:12.5 mg in 1 1
Approved: 2015/11/25
NDC:70260-430
Pyrimethamine
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:25 mg in 1 1
Approved: 2024/01/19
NDC:59651-590
Pyrimethamine Leucovorin
Manufacturer:ImprimisRx PA, Inc. d/b/a ImprimisRx
Route:ORAL
Strength:50 mg in 1 1
Approved: 2015/11/27
NDC:70271-429
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath